Home > Press > Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO as of July, 16 2007. Dr. Williams' vast experience and skills will be valuable as Platypus transitions from a start-up to a growth-phase company. Prior to joining Platypus, Dr. Williams served as Senior Vice President and was responsible for product development at Asuragen. Before joining Asuragen, he was Vice President and General Manager of Ambion Diagnostics where he was responsible for the successful commercialization of several FDA-regulated diagnostic products. In addition, Dr. Williams spent over 10 years at Roche Diagnostics where he held several senior level positions, and he was a Vice President at Roche Applied Science during the launch of the LightCycler and many new PCR-based products for life science and diagnostic markets. As a precursor to his time at Roche Applied Science, Dr. Williams was Director of Operations at Roche Molecular Systems and was responsible for the production of all Roche PCR products. Dr. Williams began his career in the bio/pharmaceutical industry at Promega Corporation where he spent six years as Director of Operations. Dr. Williams received both his BS and PhD degrees from the University of Wisconsin-Madison.
Platypus Technologies, LLC is pleased to announce that Dr. Jeff Williams has joined the Company as CEO
Madison, WI | Posted on July 17th, 2007
About Platypus Technologies, LLC
Platypus Technologies, LLC develops, produces and markets nanotechnologies for the analytic and life sciences. The Company offers a variety of nanostructured surfaces for use in research and is also developing a range of products that derive from a proprietary platform technology using liquid crystals for the rapid detection of molecular interactions. This technology fuses advances in nanoscale science, materials science, and molecular biology to provide advanced tools for use in proteomics, cell studies, environmental monitoring and in vitro diagnostics. The Company has 23 employees and is located in the Fitchburg Technology Campus.
For more information, please click here
Dr. Minnie Gupta
Director of Marketing
Copyright © Platypus Technologies, LLC
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
New method allows for greater variation in band gap tunability: The method can change a material's electronic band gap by up to 200 percent January 31st, 2015
Evidence mounts for quantum criticality theory: Findings bolster theory that quantum fluctuations drive strange electronic phenomena January 30th, 2015
Everything You Need To Know About Nanopesticides January 30th, 2015
DNA nanoswitches reveal how life's molecules connect: An accessible new way to study molecular interactions could lower cost and time associated with discovering new drugs January 30th, 2015
Hiden Gas Analysers at PITTCON 2015 | Visit us on Booth No. 1127 January 29th, 2015
Advantest to Exhibit at SEMICON Korea in Seoul, South Korea February 4-6 Showcasing Broad Portfolio of Semiconductor Products, Technologies and Solutions January 29th, 2015
Park Systems Announces Innovations in Bio Cell Analysis with the Launch of Park NX-Bio, the only 3-in-1 Imaging Nanoscale Tool Available for Life Science Researchers January 29th, 2015
2015 Nanonics Image Contest January 29th, 2015
Nexeon Board Changes Announced January 29th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015
SUNY Board Appoints Dr. Alain Kaloyeros as Founding President of SUNY Polytechnic Institute January 13th, 2015
Blend Therapeutics Appoints Distinguished Physician Scientist, Dennis Ausiello, MD, to Board of Directors January 8th, 2015